Treatment of CTLA-4 expressing tumor cell lines with recombinant forms of the CTLA-4 ligands CD80 and CD86 induced caspase-8-dependent apoptosis and the level of apoptotic tumor cells was reduced by soluble CTLA-4 and anti-CTLA-4 single-chain variable fragment antibodies [26]. The gene discussed is CD86; the disease is neoplasm.